Mutations in frequently mutated genes of gastric cancer, included in Figure 1, occurring in the MSI-high sub-set of CDX2-induced, SOX2-suppressed gastric cancers, were in the majority (53.2%) deemed pathogenic in the evaluation performed by the OncoKB knowledgebase. This evidence concerns the gene SOX2 and gastric cancer.